Tag Archives: Professor Martin Rossor: NIHR National Director for Dementia Research

Update on the Association Between Anticholinergics and Dementia Risk (BBC News / BMJ)

Posted on April 26, 2018 by Dementia and Elderly Care News

Summary A new statistical study has confirmed an association between use of certain anticholinergic drugs (commonly prescribed for the treatment of depression, Parkinson’s Disease and bladder problems) and a heightened risk of developing dementia. Other anticholinergics, taken to treat hay … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, BBC News, Community Care, Depression, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, Statistics, UK, Universal Interest | Tagged Acetylcholine, Adverse Drug Reactions (ADRs): Type A (Potentially Avoidable and Associated With Commonly Prescribed Medications), Anticholinergic Drugs, Anticholinergic Drugs and Dementia in Older Adults, Anticholinergic Drugs and Dementia Risk, Anticholinergics, Aston University, Behind the Headlines, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Cumulative Anticholinergic Use (Dementia Risk Factor), Dementia Risk Factors, Dementia Risk Reduction, Dr James Prickett: Head of Research at Alzheimer's Society, Drug Side-Effects, Epidemiology, Epidemiology and Statistics, Indiana University, Modifiable Risk Factors, Newcastle University, Potentially Harmful Medications, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing, Professor Martin Rossor: NIHR National Director for Dementia Research, Purdue University, Risk Factors, Risk Factors for Alzheimer's Diseease, Royal College of Surgeons in Ireland, Strong Anticholinergics Association With Incident Dementia, University of Aberdeen, University of Cambridge, University of East Anglia, University of Pittsburgh, University of Washington, Urinary Incontinence | Leave a comment

On the Road to Dementia? (BBC / Lancet / NHS Choices)

Posted on January 5, 2017 by Dementia and Elderly Care News

Summary Researchers following nearly 2 million Canadians in Ontario over 11 years have discovered that living close to busy roads appears to be associated with a higher incidence of dementia. It is suggested that possibly 10% of dementia cases amongst … Continue reading →

Posted in BBC News, Community Care, For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, Statistics, Universal Interest | Tagged Air Pollution, Air Pollution and Public Health, Air Pollution and Risk of Dementia, Air Pollution From Motor Exhaust Fumes, Air Quality, Airborne Particulate Matter, BBC Health News, Behind the Headlines, Canada, Canadian Health Databases, Carleton University (Ottawa), Cognitive Impairment (Potential Risk Factors), College of Public Health and Human Sciences: Oregon State University, Combustion-Derived Nanoparticles, Dalhousie University, Dalla Lana School of Public Health: University of Toronto, Department of Family and Community Medicine: University of Toronto, Department of Health Sciences: Carleton University (Ottawa), Department of Medicine: University of Toronto, Department of Physics and Atmospheric Science: Dalhousie University, Division of Neurology: University of Toronto, Environmental Risk Factors, Epidemiology, Epidemiology and Statistics, Evidence for Risk Factors of Dementia, Exposure to Air Pollution and Cognitive Functioning, Exposure to Fine Particulate Matter, Exposure to Traffic, Harvard-Smithsonian Centre for Astrophysics, Health Canada, Heavy Traffic, Institute for Clinical Evaluative Sciences (Toronto), Lancet, Life Expectancy: Variations Between Rural and Urban Areas in England, Living Close To Busy Roads, Living Within 50 Metres of a Major Road, Long-Term Exposure to Ambient Air Pollution, Modifiable Risk Factors, Multiple Sclerosis, Near-Road Exposure and Risk of Dementia, Neurodegeneration, Neurodegenerative Diseases, Neurodegenerative Disorders, Nitrogen Oxides (NOx), Noise Pollution, Ontario (Canada), Oregon State University, Population Studies Division: Health Canada, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Prof. Andy Jones: Professor of Public Health at University of East Anglia, Prof. David Newby: British Heart Foundation Professor of Cardiology at University of Edinburgh, Prof. Tom Dening: Centre for Dementia at University of Nottingham, Professor Martin Rossor: NIHR National Director for Dementia Research, Public Health, Public Health Ontario, Residence Near to Busy Roads, Residential Proximity To Major Roadways, Rurality, Small Particulate Matter (PM2.5), Statistical Digest of Rural England (2012), Sunnybrook Health Sciences Centre: University of Toronto, Ultrafine Particles, University of Toronto, Urban Environment, USA | Leave a comment

Developments in Dementia Research: From the Horses’ Mouths (NHS England / NIHR)

Posted on August 25, 2016 by Dementia and Elderly Care News

Summary Professor Alistair Burns (NHS England’s National Clinical Director for Dementia and Older Peoples’ Mental Health), and Professor Martin Rossor (NIHR National Director for Dementia Research), discuss current issues and new approaches in dementia research, touching briefly upon some of … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, National, NHS England, NIHR, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged 100000 Genomes Project, A4 Study, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alzheimer's Prevention Initiative, Alzheimer’s Disease Biomarkers, Alzheimer’s Prevention Initiative Study, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), APP and Presenilin, Asymptomatic Alzheimer’s Disease, Banner Alzheimer's Institute, Biomarkers, Chance Genetic Mutations, Colombia, Colombian Alzheimer's Prevention Initiative Registry in Medellín Antioquia, DIAN-TU Study, DIAN-TU Trial, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, Genentech, Genomics, Genomics England, Genomics in the NHS, Genomics-Based Medicine, Global Outlook, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Medellin (Colombia), Monoclonal Antibodies, MRC Neurochemical Pharmacology Unit, Mutational Signatures, National Clinical Director for Dementia, National Institute for Health Research (NIHR), National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, NIHR Clinical Research Network, NIHR Dementia Translational Research Collaboration, NIHR National Director for Dementia Research, NIHR Translational Research Collaboration, Overcoming Barriers, Participation in Research, Participation in Research Studies, Preclinical Alzheimer's Disease, Presenilin, Prodromal Alzheimer's Disease, Professor Alistair Burns, Professor Martin Rossor: Director of the NIHR Queen Square Dementia Biomedical Research Unit, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: Former President of the Association of British Neurologists (2011-2013), Professor Martin Rossor: Honorary Consultant Neurologist at National Hospital for Neurology and Neurosurgery, Professor Martin Rossor: National Hospital (Queen Square), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Promisary Science, Reducing Downstream Effects of Disease, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Sharing Knowledge and Information, Slowing Progression of Disease (Stabilisation), Solanezumab (Sola or Solab), Solanezumab: Humanised Monoclonal Antibody, Therapeutic Nihilism (Avoiding), Translational Research, UK Genomes Project: Genomics England, University of Southern California’s Alzheimer’s Therapeutic Research Institute, Washington University School of Medicine | Leave a comment

Join Dementia Research: Clinical Trials Matchmaker Service (Department of Health / Dementia Challenge / BBC News / NIHR)

Posted on February 25, 2015 by Dementia and Elderly Care News

Summary The “Join Dementia Research” website assists people with dementia to learn about, and become involved in, dementia research. A new enhancement to this service allows people with dementia (or their families / carers for example, acting on their behalf) … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, BBC News, Charitable Bodies, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, NIHR, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Personalisation, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest | Tagged Ageing, Ageing and Dementia, Alzheimer Scotland, Alzheimer's Research UK, Alzheimer's Society, BBC Health News, Dementia Challenge, Dementia Research, Dementia Research Centre (DRC) at University College London, Dementia Research Centre: University College London, Dementias and Neurodegenerative Diseases Research Network (DeNDRoN), Hilary Evans: Charity Director of Alzheimer’s Research UK, Join Dementia Research, Join Dementia Research National Service, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institute for Health Research (NIHR), NIHR: National Institute for Health Research, Non-Invasive Biomarkers, Participation in Research, Participation in Research Studies, Patient Involvement in Research, Patient Participation Groups, Patient Participation Groups (PPGs), Practice Participation Groups, Pre-Dementia (MCI), Prime Minister's Challenge on Dementia, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Public Involvement in Research, Public Participation in Research, Research Engagement and Involvement Activities, Science of Ageing, Small Business Research Initiative for Healthcare (SBRI) Healthcare Programme, UCL Partners, University College London, University College London (UCL) | Leave a comment

Interim “Big Picture” Review of Progress and Developments in the NHS (Department of Health)

Posted on January 9, 2015 by Dementia and Elderly Care News

Summary This document provides a brief summary of progress made against the Department of Health’s objectives, financial performance, people and major projects (in the Government’s Major Projects Portfolio) between April and September 2014. Full Text Link Reference Mid-year report 2014-15: … Continue reading →

Posted in Acute Hospitals, Commissioning, Community Care, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Person-Centred Care, Public Health England, Quick Insights, Standards, UK | Tagged Adult Social Care, Arm’s Length Bodies, Arm’s Length Bodies (Department of Health's ALBs), Better Care Fund (BCF), Care Act 2014, Caring Better, Challenge on Dementia, Challenge on Dementia (David Cameron), Dementia Research, Department of Health Arm’s Length Bodies, Department of Health's Arm’s Length Bodies (ALBs), Department of Health's Mid-Year Report 2014-15, Early Diagnosis, Health and Social Care, Health and Social Care Integration, Health and Social Care Reform, Improving Treatment and Care of People With Dementia, Integration of Health and Social Care, Living and Ageing Well, Local Government and Care Partnerships), Mid-Year Report 2014-15: Department of Health, NIHR National Director for Dementia Research, PHE: Public Health England, Primary Care’s Role in Early Diagnosis, Prime Minister's Challenge on Dementia, Professor Martin Rossor: NIHR National Director for Dementia Research, Public Health England (PHE), Social Care Reform, Think Local Act Personal (TLAP), TLAP: Think Local Act Personal, UK Government’s Major Projects Portfolio, World Dementia Council | Leave a comment

National Dementia Policy: Formation of Dementia Advisory Group (Department of Health / Dementia Challenge)

Posted on December 21, 2014 by Dementia and Elderly Care News

Summary The Department of Health intends to publish a renewed “vision” for strategic direction, with plans up to 2020, on the future of dementia policy in England. It should be ready by early 2015. This will continue and extend existing … Continue reading →

Dementia Care, Patient Experience and Risk Reduction Are Priorities for World Dementia Council (Department of Health / Dementia Challenge / WDC)

Posted on November 30, 2014 by Dementia and Elderly Care News

Summary It has been agreed at the World Dementia Council‘s third meeting in London (held at the Foreign and Commonwealth Office on Friday October 17th 2014) that dementia care (i.e. health and social care) and risk reduction should be added … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest, World Health Organization (WHO) | Tagged Achieving Dementia Friendly Acute care, Alzheimer's Research UK, Alzheimer’s Disease International (ADI), Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Challenge on Dementia (David Cameron), Collaborative Projects, Community Rehabilitation, Continuity Plans (WDC and GAAD Agenda), Conversion to Dementia From Prodromal Disease, Cross-Sector Partnerships, Danish Health and Medicines Authority, Dementia Alliance International, Dementia Awareness, Dementia Challenge, Dementia Risk Factors, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health's Digital Health Blog, Digital Engagement, Dr Kiyoshi Kurokawa: Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan, Dr Margaret Chan: WHO Director-General, European Medicines Agency, Experiences, Experiences of Diagnosis, Experts by Experience, F ederal Institute for Drugs and Medical Devices Germany, Finance and Incentives, Fourth World Dementia Council Meeting (February 2015), G7 Countries, G7 Global Dementia Summit, G8 Dementia Summit, GADAA Toolkit: Global Alzheimer’s and Dementia Action Alliance, Geoff Huggins: Scottish Government, Global Action Against Dementia, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Harry Johns: President and CEO of Alzheimer’s Association, Harry Johns: World Dementia Council Member, Health Canada, Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Hilary Doxford: World Dementia Council Member, Innovation in Care and Prevention (Japan Legacy Event), Innovative Technology, Integrated Development, International Collaborations, International Dementia Research Inventories, International Programmes, Italian Medicines Agency, Japan Legacy Event, Japan Legacy Event: Innovation in Care and Prevention, Japan’s G7 Legacy Event on Dementia Care and Prevention, JP Morgan, Kate Swaffer: Chair of Dementia Alliance International, Legacy Event in March 2015, Lifestyle Risk Factors, Lived Experience, Living Well with Dementia, Living Well with Dementia Research, Maintaining Independence, Medicines and Healthcare Products Regulatory Authority UK, Medicines Evaluation Board Netherlands, Modifiable Risk Factors, Open Science and Data, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Cooperation and Development, Partnership and Collaboration, Partnership Working, Patient Experience, Personal Experience of Dementia, Peter Paniccia, Pharmaceutical and Medical Devices Agency Japan, Pharmaceutical Industry, Pharmaceutical Regulators, Pre-Clinical Fund, Pre-Clinical Space, Prescribed Disengagement, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Prodromal Alzheimer's Disease, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Reablement, Reablement Services, Regaining Independence, Rehabilitation, Rehabilitation and Self Management, Research and Innovation, Resource and Incentives, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Reduction (Formerly Termed Prevention by WDC), Science and Innovation, Service User Experience, Sir Mark Walport, Sir Mark Walport (Wellcome Trust), Specialist Rehabilitation Services, Staying Independent, Support for Carers, Sustainable Care, Tackling Barriers to Innovation, Third Global Dementia Legacy Event, Third Global Dementia Legacy Event (Japan: November 2014), Third World Dementia Council Meeting Communique, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, US Food and Drug Administration, WDC Dementia Risk Reduction Statement, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), World Health Organization (WHO) | Leave a comment

Tag Archives: Professor Martin Rossor: NIHR National Director for Dementia Research

Update on the Association Between Anticholinergics and Dementia Risk (BBC News / BMJ)

On the Road to Dementia? (BBC / Lancet / NHS Choices)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites